News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,114 Results
Type
Article (2574)
Company Profile (45)
Press Release (37494)
Multimedia
Podcasts (9)
Webinars (2)
Section
Business (14200)
Career Advice (78)
Deals (2108)
Drug Delivery (9)
Drug Development (4144)
Employer Resources (10)
FDA (443)
Job Trends (783)
News (20284)
Policy (1060)
Tag
Academia (144)
Allergies (7)
Alliances (3493)
ALS (6)
Alzheimer's disease (59)
Antibody-drug conjugate (ADC) (27)
Approvals (446)
Artificial intelligence (31)
Autoimmune disease (8)
Automation (2)
Bankruptcy (12)
Best Places to Work (477)
BIOSECURE Act (2)
Biosimilars (16)
Biotechnology (29)
Bladder cancer (8)
Brain cancer (7)
Breast cancer (44)
Cancer (324)
Cardiovascular disease (10)
Career advice (66)
Career pathing (1)
CAR-T (31)
CDC (1)
Cell therapy (81)
Cervical cancer (2)
Clinical research (3438)
Collaboration (199)
Company closure (2)
Compensation (104)
COVID-19 (185)
CRISPR (11)
C-suite (112)
Cystic fibrosis (7)
Data (419)
Denatured (6)
Depression (11)
Diabetes (17)
Diagnostics (488)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (36)
Drug pricing (10)
Duchenne muscular dystrophy (40)
Earnings (4500)
Editorial (5)
Employer branding (1)
Employer resources (8)
Events (6403)
Executive appointments (134)
FDA (588)
Friedreich's ataxia (4)
Frontotemporal dementia (1)
Funding (167)
Gene editing (32)
Generative AI (1)
Gene therapy (55)
GLP-1 (63)
Government (158)
Guidances (24)
Healthcare (708)
HIV (1)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (34)
Immuno-oncology (14)
Indications (4)
Infectious disease (197)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (26)
Interviews (7)
IPO (1003)
IRA (7)
Job creations (293)
Job search strategy (62)
JPM (4)
Kidney cancer (6)
Labor market (11)
Layoffs (51)
Leadership (3)
Legal (215)
Liver cancer (6)
Longevity (1)
Lung cancer (28)
Lymphoma (12)
Machine learning (3)
Management (4)
Manufacturing (52)
MASH (14)
Medical device (314)
Medtech (315)
Mergers & acquisitions (1221)
Metabolic disorders (72)
Multiple sclerosis (22)
Neurodegenerative disease (27)
Neuropsychiatric disorders (10)
Neuroscience (164)
NextGen: Class of 2026 (353)
Non-profit (155)
Now hiring (11)
Obesity (32)
Opinion (17)
Ovarian cancer (17)
Pain (24)
Pancreatic cancer (21)
Parkinson's disease (11)
Partnered (4)
Patents (54)
Patient recruitment (25)
Peanut (1)
People (5883)
Pharmaceutical (5)
Phase 1 (1475)
Phase 2 (1702)
Phase 3 (915)
Pipeline (392)
Policy (16)
Postmarket research (30)
Preclinical (640)
Press Release (2)
Prostate cancer (7)
Psychedelics (3)
Radiopharmaceuticals (14)
Rare diseases (62)
Real estate (425)
Recruiting (5)
Regulatory (920)
Reports (7)
Research institute (149)
Resumes & cover letters (9)
Rett syndrome (1)
RNA editing (5)
RSV (1)
Schizophrenia (16)
Series A (46)
Series B (20)
Service/supplier (2)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (497)
Stomach cancer (2)
Supply chain (4)
Tariffs (2)
The Weekly (3)
Vaccines (52)
Venture capital (15)
Weight loss (21)
Women's health (10)
Worklife (1)
Date
Today (1)
Last 7 days (39)
Last 30 days (164)
Last 365 days (2415)
2026 (211)
2025 (2441)
2024 (2613)
2023 (2858)
2022 (3750)
2021 (4049)
2020 (3471)
2019 (2062)
2018 (1554)
2017 (1795)
2016 (1632)
2015 (1842)
2014 (1370)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
Location
Africa (44)
Alabama (3)
Arizona (18)
Asia (1946)
Australia (307)
California (1606)
Canada (241)
China (80)
Colorado (54)
Connecticut (16)
Delaware (5)
Europe (4016)
Florida (64)
Georgia (11)
Hawaii (2)
Idaho (3)
Illinois (21)
India (2)
Indiana (60)
Japan (17)
Kansas (14)
Kentucky (1)
Maryland (48)
Massachusetts (568)
Michigan (14)
Minnesota (22)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (133)
New York (80)
North Carolina (131)
Northern California (785)
Ohio (44)
Oklahoma (2)
Oregon (6)
Pennsylvania (109)
Puerto Rico (1)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (652)
Tennessee (4)
Texas (152)
United States (3207)
Utah (5)
Virginia (11)
Washington D.C. (3)
Washington State (95)
West Virginia (1)
Wisconsin (13)
40,114 Results for "evofem biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Evofem Biosciences’ CEO Saundra Pelletier Joins Aditxt Board of Directors
June 9, 2025
·
5 min read
Business
Evofem Biosciences Announces Financial Results for the First Quarter of 2024
The company behind the hormone-free contraceptive Phexxi®, Evofem Biosciences, Inc. announced financial results for the first quarter of 2024.
May 15, 2024
·
7 min read
Press Releases
Saundra Pelletier, Evofem Biosciences’ CEO, Dr. Friedrich Kapp, Co-CEO of Adimune, and Chris Mitton, President of Pearsanta, Will Join Aditxt Weekly Update on June 6
June 5, 2025
·
4 min read
Deals
Aditxt, Inc. Enters into Definitive Agreement to Acquire Evofem Biosciences, Inc.
Aditxt, Inc. Enters into Definitive Agreement to Acquire Evofem Biosciences, Inc.
December 12, 2023
·
13 min read
Business
Evofem Biosciences Announces Financial Results for the Third Quarter of 2023
Evofem Biosciences, Inc. (OTCQB: EVFM) today announced financial results for the third quarter and nine months ended September 30, 2023.
November 14, 2023
·
8 min read
Press Releases
Evofem Biosciences Files Preliminary Proxy for Stockholder Approval of the Acquisition by Aditxt
September 24, 2024
·
6 min read
Biotech Beach
Evofem Announces Issuance of New U.S. Patent Covering Phexxi Composition of Matter
Evofem Biosciences, Inc. (OTCQB: EVFM) today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,992,472, which covers composition and methods for contraception with a composition that encompasses Phexxi® (lactic acid, citric acid, and potassium bitartrate) vaginal gel.
June 11, 2024
·
3 min read
Business
Evofem Biosciences Announces Financial Results for the Second Quarter of 2023
Evofem Biosciences, Inc. (OTCQB: EVFM) today announced financial results for the second quarter and first half of 2023.
August 14, 2023
·
7 min read
Biotech Beach
Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023
The company behind Phexxi® vaginal gel, women’s health innovator Evofem Biosciences, Inc., announced financial results for the fourth quarter and year ended December 31, 2023.
March 27, 2024
·
8 min read
Biotech Beach
Evofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023
Evofem Biosciences, Inc. (OTCQB: EVFM) today announced strong preliminary, unaudited results for fiscal 2023, including record net sales of Phexxi® (lactic acid, citric acid, and potassium bitartrate), its hormone-free contraceptive gel, and the Company’s lowest total operating expenses since becoming a commercial stage company in 2020.
February 1, 2024
·
3 min read
1 of 4,012
Next
